Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Transgenic coagulation factor XIII defective animal and its use for testing wound healing and bleeding

Transgenic coagulation factor XIII defective animal and its use for testing wound healing and bleeding

US Patent 6207877 · Granted Mar 27, 2001

Estimated economic value: $8,540,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Process for preparing 4-methyl-2-propan-2-yl-pyridine-3-carbonitrile2025
Ring closing synthesis of macrocyclic MCL-1 inhibitor intermediates2025
Synthesis of vinylic protected alcohol intermediates2025
Truncated von Willebrand Factor polypeptides for treating hemophilia2023
Pharmaceutical formulations of C1 esterase inhibitor2023
Method for improving the stability of purified Factor VIII after reconstitution2022
Protein purification and virus inactivation with alkyl glycosides2022
Modified von Willebrand factor having improved half-life2021
Resetting pluripotent stem cells2021
Method for improving the stability of purified Factor VIII after reconstitution2021
Truncated von Willebrand factor polypeptides for treating hemophilia2020
Method for improving the stability of purified factor VIII after reconstitution2020